Summary & Overview
HCPCS A2021: Neomatrix per Square Centimeter (Add-on Supply)
HCPCS Level II code A2021 represents Neomatrix billed per square centimeter as an add-on product used in tissue repair or reconstruction. As a supply add-on, it is reported in addition to a primary procedure and is relevant to surgical specialties that use biologic matrices, including plastic surgery, general surgery, and wound care. Nationally, add-on supply codes affect procedure-level reimbursement and utilization tracking, making clear coding essential for accurate payment and clinical documentation.
Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The report examines how A2021 is described, common billing practice implications, and typical sites of service such as ambulatory surgical centers and hospital outpatient departments.
Readers will learn the clinical context for use of Neomatrix, how the code functions as an add-on supply, and what to expect in payer coverage considerations at a national level. The publication outlines benchmarks and billing considerations where available, highlights documentation points that support use as an adjunct to primary procedures, and summarizes policy elements relevant to payers and facility billing. Data not available in the input will be noted where applicable.
Billing Code Overview
HCPCS Level II code A2021 describes Neomatrix, billed per square centimeter as an add-on supply or product that must be listed separately in addition to a primary procedure. The service type is implantable/biologic matrix material used to support tissue repair or reconstruction. The typical site of service for this item is ambulatory surgical centers and hospital outpatient departments, and it may also be used in inpatient surgical settings when documented as an add-on product.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult with a full-thickness or deep partial-thickness skin defect from trauma, surgical excision (e.g., tumor removal), chronic non-healing ulceration, or debridement of necrotic tissue. The clinical workflow begins with evaluation in an outpatient surgical or wound clinic or inpatient surgical service. After wound bed preparation and debridement, the surgeon or wound care specialist applies Neomatrix biologic scaffold material measured and billed per square centimeter (A2021) as an add-on to the primary reconstructive or wound procedure. The application commonly occurs in an operating room, procedure suite, or ambulatory surgical center under local, regional, or general anesthesia. Post-application care includes dressing changes, infection surveillance, and follow-up visits to assess graft incorporation and wound healing. Documentation must link A2021 to the primary procedure and clinical indication, specify the number of square centimeters applied, and include the performing provider, site of service, and necessary modifiers for billing.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | Default four-position modifier (no special reporting) |